Cargando…
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial
The purpose of this randomized trial was to compare the efficacy of 6 cycles of prednisolone, Adriamycin (doxorubicin), bleomycin, vincristine (Oncovin) and etoposide (PABlOE) with 3 cycles of PABIOE that alternate with 3 cycles of chlorambucil, vinblastine, procarbazine and prednisone (ChlVPP) in p...
Autores principales: | Hancock, B W, Gregory, W M, Cullen, M H, Hudson, G Vaughan, Burton, A, Selby, P, Maclennan, K A, Jack, A, Bessell, E M, Smith, P, Linch, D C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363648/ https://www.ncbi.nlm.nih.gov/pubmed/11355937 http://dx.doi.org/10.1054/bjoc.2001.1778 |
Ejemplares similares
-
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
por: Selby, P., et al.
Publicado: (1990) -
Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphoma
por: Cocorocchio, E, et al.
Publicado: (2010) -
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
por: Dady, P. J., et al.
Publicado: (1982) -
Pablo Casals
por: Montiel Rubén
Publicado: (1973) -
Pablo Milanes
Publicado: (1985)